Literature DB >> 3117241

Liver disease and platelet function in alcoholics.

M Hillbom1, A Muuronen, J Neiman.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3117241      PMCID： PMC1248749          DOI： 10.1136/bmj.295.6598.581

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Platelet function defects in chronic alcoholism.

Authors:  D P Mikhailidis; W J Jenkins; M A Barradas; J Y Jeremy; P Dandona
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

2.  Platelet thromboxane production in liver cirrhosis.

Authors:  G Davì; G Migneco; S Vigneri; S Tripi; A Scialabba; A Strano
Journal:  Prostaglandins Leukot Med       Date:  1985-07

3.  Platelet thromboxane formation and bleeding time is influenced by ethanol withdrawal but not by cigarette smoking.

Authors:  M Hillbom; A Muuronen; C Löwbeer; E Anggård; H Beving; M Kangasaho
Journal:  Thromb Haemost       Date:  1985-06-24       Impact factor: 5.249

4.  Thromboxane A2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid.

Authors:  M Thorngren; S Shafi; G V Born
Journal:  Lancet       Date:  1983-05-14       Impact factor: 79.321

5.  Abnormal polyunsaturated fatty acid patterns of serum lipids in alcoholism and cirrhosis: arachidonic acid deficiency in cirrhosis.

Authors:  S B Johnson; E Gordon; C McClain; G Low; R T Holman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205
  5 in total
  1 in total

1.  Prevalence of disease and relationships between laboratory phenotype and bleeding severity in platelet primary secretion defects.

Authors:  Luca A Lotta; Alberto Maino; Giacomo Tuana; Raffaella Rossio; Anna Lecchi; Andrea Artoni; Flora Peyvandi
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.